Cargando…

Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein

We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considere...

Descripción completa

Detalles Bibliográficos
Autores principales: Otsuru, Toru, Kobayashi, Shogo, Wada, Hiroshi, Takahashi, Tsuyoshi, Gotoh, Kunihito, Iwagami, Yoshifumi, Yamada, Daisaku, Noda, Takehiro, Asaoka, Tadafumi, Serada, Satoshi, Fujimoto, Minoru, Eguchi, Hidetoshi, Mori, Masaki, Doki, Yuichiro, Naka, Testuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398893/
https://www.ncbi.nlm.nih.gov/pubmed/30575211
http://dx.doi.org/10.1111/cas.13918
_version_ 1783399663494234112
author Otsuru, Toru
Kobayashi, Shogo
Wada, Hiroshi
Takahashi, Tsuyoshi
Gotoh, Kunihito
Iwagami, Yoshifumi
Yamada, Daisaku
Noda, Takehiro
Asaoka, Tadafumi
Serada, Satoshi
Fujimoto, Minoru
Eguchi, Hidetoshi
Mori, Masaki
Doki, Yuichiro
Naka, Testuji
author_facet Otsuru, Toru
Kobayashi, Shogo
Wada, Hiroshi
Takahashi, Tsuyoshi
Gotoh, Kunihito
Iwagami, Yoshifumi
Yamada, Daisaku
Noda, Takehiro
Asaoka, Tadafumi
Serada, Satoshi
Fujimoto, Minoru
Eguchi, Hidetoshi
Mori, Masaki
Doki, Yuichiro
Naka, Testuji
author_sort Otsuru, Toru
collection PubMed
description We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considered to play a key role in epithelial‐mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG‐related EMT in relation to metastasis in PDAC. We cultured LRG‐overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT‐related molecules and TGF‐β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle‐like shape was visualized more frequently than other shapes in Panc1/LRG with TGF‐β1 exposure. The expression of E‐cadherin in Panc1/LRG was decreased with TGF‐β1 exposure. Invasion increased with TGF‐β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF‐β1 stimulation. In the plasma LRG‐high group, the recurrence rate tended to be higher and the recurrence‐free survival (RFS) tended to be worse in comparison with the plasma LRG‐low group. LRG enhanced EMT induced by TGF‐β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC.
format Online
Article
Text
id pubmed-6398893
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63988932019-03-14 Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein Otsuru, Toru Kobayashi, Shogo Wada, Hiroshi Takahashi, Tsuyoshi Gotoh, Kunihito Iwagami, Yoshifumi Yamada, Daisaku Noda, Takehiro Asaoka, Tadafumi Serada, Satoshi Fujimoto, Minoru Eguchi, Hidetoshi Mori, Masaki Doki, Yuichiro Naka, Testuji Cancer Sci Original Articles We previously showed that an inflammation‐related, molecule leucine‐rich alpha‐2 glycoprotein (LRG) enhances the transforming growth factor (TGF)‐β1‐induced phosphorylation of Smad proteins and is elevated in patients with pancreatic ductal adenocarcinoma (PDAC). As TGF‐β/Smad signaling is considered to play a key role in epithelial‐mesenchymal transition (EMT), we attempted to clarify the mechanism underlying LRG‐related EMT in relation to metastasis in PDAC. We cultured LRG‐overexpressing PDAC cells (Panc1/LRG) and evaluated the morphology, EMT‐related molecules and TGF‐β/Smad signaling pathway in these cells. We also assessed the LRG levels in plasma and resected specimens from patients with PDAC. Inflammatory cytokines induced LRG production in PDAC cells. A spindle‐like shape was visualized more frequently than other shapes in Panc1/LRG with TGF‐β1 exposure. The expression of E‐cadherin in Panc1/LRG was decreased with TGF‐β1 exposure. Invasion increased with TGF‐β1 stimulation of Panc1/LRG. The phosphorylation of smad2 in Panc1/LRG was increased in comparison with parental Panc1 under TGF‐β1 stimulation. In the plasma LRG‐high group, the recurrence rate tended to be higher and the recurrence‐free survival (RFS) tended to be worse in comparison with the plasma LRG‐low group. LRG enhanced EMT induced by TGF‐β signaling, thus indicating that LRG has a significant effect on the metastasis of PDAC. John Wiley and Sons Inc. 2019-02-04 2019-03 /pmc/articles/PMC6398893/ /pubmed/30575211 http://dx.doi.org/10.1111/cas.13918 Text en © 2018 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Otsuru, Toru
Kobayashi, Shogo
Wada, Hiroshi
Takahashi, Tsuyoshi
Gotoh, Kunihito
Iwagami, Yoshifumi
Yamada, Daisaku
Noda, Takehiro
Asaoka, Tadafumi
Serada, Satoshi
Fujimoto, Minoru
Eguchi, Hidetoshi
Mori, Masaki
Doki, Yuichiro
Naka, Testuji
Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title_full Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title_fullStr Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title_full_unstemmed Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title_short Epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
title_sort epithelial‐mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine‐rich alpha‐2 glycoprotein
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398893/
https://www.ncbi.nlm.nih.gov/pubmed/30575211
http://dx.doi.org/10.1111/cas.13918
work_keys_str_mv AT otsurutoru epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT kobayashishogo epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT wadahiroshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT takahashitsuyoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT gotohkunihito epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT iwagamiyoshifumi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT yamadadaisaku epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT nodatakehiro epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT asaokatadafumi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT seradasatoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT fujimotominoru epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT eguchihidetoshi epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT morimasaki epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT dokiyuichiro epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein
AT nakatestuji epithelialmesenchymaltransitionviatransforminggrowthfactorbetainpancreaticcancerispotentiatedbytheinflammatoryglycoproteinleucinerichalpha2glycoprotein